Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|April 3, 2023
Design, synthesis, structure-activity relationship studies, and evaluation of novel GLS1 inhibitorsMichiko Jo, Keiichi Koizumi, Mizuho Suzuki, et al.
AMB Express|August 16, 2013
Overexpression of an antimicrobial peptide derived from C. elegans using an aggregation-prone protein coexpression systemSatoshi Tomisawa, Eri Hojo, Yoshitaka Umetsu, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2017
Design, synthesis, and evaluation of novel inhibitors for wild-type human serine racemaseSatoyuki Takahara, Kiyomi Nakagawa, Tsugumi Uchiyama, et al.
Journal of Medicinal Chemistry|December 6, 2022
Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin AmyloidogenesisMineyuki Mizuguchi, Yusuke Nakagawa, Kishin Inui, et al.
The Biochemical Journal|June 15, 2011
Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosisHirofumi Jono, Takayuki Anno, Keiichi Motoyama, et al.
Clinical Chemistry|April 18, 2009
SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathyMitsuharu Ueda, Yohei Misumi, Mineyuki Mizuguchi, et al.
Proteins|January 25, 2008
Structural properties of the DNA-bound form of a novel tandem repeat DNA-binding domain, STPRShin Saito, Takuya Yokoyama, Tomoyasu Aizawa, et al.
Nature Communications|November 16, 2021
Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammationMeihua Jin, Hiroki Shiwaku, Hikari Tanaka, et al.
The American Journal of Pathology|November 11, 2018
The Accumulation of Heparan Sulfate S-Domains in Kidney Transthyretin Deposits Accelerates Fibril Formation and Promotes CytotoxicityHirokazu Kameyama, Kenji Uchimura, Taro Yamashita, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 25, 2012
Potential use of glucuronylglucosyl-β-cyclodextrin as a novel therapeutic tool for familial amyloidotic polyneuropathyHirofumi Jono, Takayuki Anno, Keiichi Motoyama, et al.
Pageof 13